Search

Search Constraints

You searched for: Author/Creator Lucchesi, Davide

Search Results

2. 345 Treatment with amlitelimab—a novel non-depleting, non-cytotoxic anti-OX40Ligand monoclonal antibody—reduces IL-22 serum levels in a phase 2a randomized, placebo-controlled trial in patients with moderate-to-severe atopic dermatitis. (25th January 2023)

3. Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren's syndrome. (21st November 2020)

5. CXCL13 as biomarker for histological involvement in Sjögren's syndrome. (4th July 2019)

8. Impaired Interleukin‐27–Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome. Issue 9 (21st July 2020)

9. Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis. (3rd September 2019)

10. NK cell recruitment in salivary glands provides early viral control but is dispensable for tertiary lymphoid structure formation. Issue 3 (21st December 2018)